To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

NCT00152893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: chromium nicotinate
DRUG: Placebo

Sponsor

Johane Allard

Collaborators

[object Object]